Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14 and IL-13 genes

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 6, 2006, Pages 800-806

  Bernstein, David I ^a   Wang, Ning ^b   Campo, Paloma ^a   Chakraborty, Ranajit ^a   Smith, Andrew ^a   Cartier, André ^c   Boulet, Louis Philippe ^d   Malo, Jean Luc ^c   Yucesoy, Berran ^e   Luster, Michael ^e   Tarlo, Susan M ^f   Hershey, Gurjit K Khurana ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; HEXAMETHYLENE DIISOCYANATE; INTERLEUKIN 13; INTERLEUKIN 4 RECEPTOR ALPHA;

ADULT; ARTICLE; ASTHMA; CD 14 GENE; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IL 13 GENE; IL4RA GENE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33845952668     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60972-6     Document Type: Article

References (51)

1. Meyer JD, Holt DL, Cherry NM, et al. SWORD '98: surveillance of work-related and occupational respiratory disease in the UK. Occup Med (Lond). 1999;49:485-489.
2. McDonald JC, Keynes HL, Meredith SK. Reported incidence of occupational asthma in the United Kingdom, 1989-97. Occup Environ Med. 2000;57:823-829.
3. Seguin P, Allard A, Cartier A, et al. Prevalence of occupational asthma in spray painters exposed to several types of isocyanates, including polymethylene polyphenylisocyanate. J Occup Med. 1987;29:340-344.
4. Bernstein DI, Korbee L, Stauder T, et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol. 1993;92: 387-396.
5. Bernstein DI. Allergic reactions to workplace allergens. JAMA. 1997;278:1907-1913.
6. Lemiere C, Cartier A, Dolovich J, et al. Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med. 1996;154:329-333.
7. Cartier A, Grammer L, Malo JL, et al. Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol. 1989;84:507-514.
8. Bernstein DI, Cartier A, Cote J, et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med. 2002;166: 445-450.
9. Tee RD, Cullinan P, Welch J, et al. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709-715.
10. Mapp CE, Beghe B, Balboni A, et al. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy. 2000;30:651-656.
11. Mapp CE, Balboni A, Baricordi R, et al. Human leukocyte antigen associations in occupational asthma induced by isocyanates. Am J Respir Crit Care Med. 1997;156:8139-43.
12. Piirila P, Wikman H, Luukkonen R, et al. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics. 2001;11:437-445.
13. Mapp CE, Fryer AA, De Marzo N, et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol. 2002; 109:867-872.
14. Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol. 2003;111:677-690; quiz 91.
15. Tomkinson A, Duez C, Cieslewicz G, et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol. 2001;166:5792-5800.
16. Rosenwasser LJ. Genetics of atopy and asthma: promoter-based candidate gene studies for IL-4. Int Arch Allergy Immunol. 1997;113:61-64.
17. Rosenwasser LJ, Klemm DJ, Dresback JK, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy. 1995;25(suppl 2):74-8; discussion 95-6.
18. Graves PE, Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol. 2000;105:506-513.
19. van der Pouw Kraan TC, van Veen A, Boeije LC, et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun. 1999;1:61-65.
20. Mitsuyasu H, Izuhara K, Mao XQ, et al. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet. 1998;19:119-120.
21. Herrick CA, Das J, Xu L, et al. Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: genetic control of TH2-induced lung inflammation. J Allergy Clin Immunol. 2003; 111:1087-1094.
22. Dearman RJ, Moussavi A, Kemeny DM, et al. Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology. 1996;89:502-510.
23. Matheson JM, Lange RW, Lemus R, et al. Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI). Clin Exp Allergy. 2001;31:1067-1076.
24. Herrick CA, Xu L, Wisnewski AV, et al. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol. 2002;109:873-878.
25. Maestrelli P, Occari P, Turato G, et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy. 1997;27:1292-1298.
26. Jones MG, Floyd A, Noun-Aria KT, et al. Is occupational asthma to diisocyanates a non-IgE-mediated disease? J Allergy Clin Immunol. 2006;117:663-669.
27. Hargreave FE, Ryan G, Thomson NC, et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol. 1981;68: 347-355.
28. Vandenplas O, Malo JL. Inhalation challenges with agents causing occupational asthma. Eur Respir J. 1997;10: 2612-2629.
29. Hargreave FE, Ramsdale EH, Sterk PJ, et al. Advances in the use of inhalation provocation tests in clinical evaluation. Chest. 1985;87:32S-5S.
30. Perrin B, Cartier A, Ghezzo H, et al. Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents. J Allergy Clin Immunol. 1991; 87:630-639.
31. Risma KA, Wang N, Andrews RP, et al. V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function. J Immunol. 2002;169:1604-1610.
32. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978-989.
33. Nicholson PJ, Cullinan P, Taylor AJ, et al. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med. 2005;62:290-299.
34. Weiss ST. Association studies in asthma genetics. Am J Respir Crit Care Med. 2001;164:2014-2015.
35. Malo JL, Ghezzo H, L'Archeveque J, et al. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis. 1991;143:528-532.
36. Bernstein DI, Jolly A. Current diagnostic methods for diisocyanate induced occupational asthma. Am J Ind Med. 1999;36: 459-468.
37. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev. 2004;202:175-190.
38. Heinzmann A, Mao XQ, Akaiwa M, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet. 2000;9:549-559.
39. Liu X, Nickel R, Beyer K, et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol. 2000;106:167-170.
40. Hershey GK, Friedrich MF, Esswein LA, et al. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med. 1997;337:1720-1725.
41. Kruse S, Japha T, Tedner M, et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology. 1999;96:365-371.
42. Ober C, Leavitt SA, Tsalenko A, et al. Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet. 2000;66:517-526.
43. Rosa-Rosa L, Zimmermann N, Bernstein JA, et al. The R576 IL-4 receptor alpha allele correlates with asthma severity. J Allergy Clin Immunol. 1999;104:1008-1014.
44. Wisnewski AV, Herrick CA, Liu Q, et al. Human gamma/delta T-cell proliferation and IFN-gamma production induced by hexamethylene diisocyanate. J Allergy Clin Immunol. 2003; 112:538-546.
45. Sade K, Kivity S, Levy A, et al. The effect of specific immunotherapy on T-cell receptor repertoire in patients with allergy to house-dust mite. Allergy. 2003;58:430-434.
46. Chauhan B, Hutcheson PS, Slavin RG, et al. T-cell receptor bias in patients with allergic bronchopulmonary aspergillosis. Hum Immunol. 2002;63:286-294.
47. Maestrelli P, Del Prete GF, De Carli M, et al. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health. 1994;20:376-381.
48. Chen W, Ericksen MB, Levin LS, et al. Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants. J Allergy Clin Immunol. 2004;114: 553-560.
49. Vladich FD, Brazille SM, Stern D, et al. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest. 2005;115:747-754.
50. Koppelman GH, Reijmerink NE, Colin Stine O, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med. 2001;163:965-969.
51. Ober C. Perspectives on the past decade of asthma genetics. J Allergy Clin Immunol. 2005;116:274-278.